XML 49 R38.htm IDEA: XBRL DOCUMENT v3.24.3
Equity Incentive Plans and Stock-Based Compensation (Tables)
 6 Months Ended
Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity and Activity Regarding Shares Available for Grant
Stock option activity and activity regarding shares available for grant under the Second A&R Plan are as follows:
Options Outstanding
Outstanding
Stock
Options 		Weighted-Average
Exercise Price		Weighted-Average
Remaining
Contractual
Life (Years)		Aggregate
Intrinsic
Value
(in thousands, except share, years, and per share data)
Balance as of March 31, 20243,537,668$73.62 5.1$306 
Granted88,615$6.82 
Exercised(6,889)$8.46 
Canceled/forfeited/expired(484,544)$86.04 
Balance as of September 30, 20243,134,850$69.95 5.0$43 
Vested and exercisable as of September 30, 20242,457,428$78.52 4.1$31 
Schedule of Weighted Average Black-Scholes Assumptions
The weighted average Black-Scholes assumptions used to value stock options at the grant dates are as follows:
Three Months Ended September 30,Six Months Ended September 30,
2024202320242023
Min
Max
Min
Max
Min
Max
Min
Max
Expected term (years)6.06.05.86.06.06.05.86.0
Expected volatility range75 %75 %78 %79 %75 %75 %78 %79 %
Expected weighted-average volatility75%79%75%79%
Risk-free interest rate3.5 %3.5 %4.4 %4.4 %3.5 %3.5 %3.6 %4.4 %
Expected dividend yield— — — — — — — — 
The per share weighted average grant date fair value of shares issued pursuant to the A&R ESPP for the six months ended September 30, 2024 and 2023 was $2.52 and $8.78, respectively, using the following assumptions:
Three Months Ended September 30,Six Months Ended September 30,
2024202320242023
Min
Max
Min
Max
Min
Max
Min
Max
Expected term (years)0.51.00.51.00.51.00.51.0
Expected volatility76 %77 %67 %73 %76 %77 %67 %73 %
Expected weighted-average volatility76%70%76%70%
Risk-free interest rate4.4 %4.8 %5.4 %5.5 %4.4 %4.8 %5.4 %5.5 %
Expected dividend yield— — — — — — — — 
Schedule of Restricted Stock Awards Activity under the Equity Incentive Plan
The following table summarizes the RSU activity under the equity incentive plans and related information:
 Unvested RSUs Weighted-Average
Grant Date Fair
Value Per Share
Balance as of March 31, 20242,203,078$45.86 
Granted3,070,895$9.36 
Vested(1,276,111)$26.41 
Canceled/forfeited(595,865)$22.24 
Balance as of September 30, 20243,401,997$24.34 
Schedule of Share Based Compensation Expense
Total stock-based compensation expense, including stock-based compensation expense related to awards classified as liabilities, was included in costs and expenses as follows:
 Three Months Ended September 30,Six Months Ended September 30,
 2024202320242023
 (in thousands)
Cost of service revenue$871 $1,041 $1,847 $3,099 
Cost of product revenue442 456 835 870 
Research and development8,565 10,938 19,636 22,630 
Sales and marketing2,155 2,016 4,614 3,734 
General and administrative (1)
7,150 9,290 13,828 43,866 
Restructuring and other charges303 — 303 641 
Total stock-based compensation expense$19,486 $23,741 $41,063 $74,840 
(1)Includes $22.0 million of stock-based compensation charges related to the termination of a Former Lemonaid Officer during the six months ended September 30, 2023.